Looking Into Immunogen's Return On Capital Employed

By: via Benzinga
Immunogen (NASDAQ:IMGN) brought in sales totaling $15.38 million during Q3 according to data provided by Benzinga Pro. However, earnings ...
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.